Methicillin-resistant Staphylococcus aureus biofilm regulatory and adhesin genes and associated metabolites (MRSA biofilm machinery)

Methicillin-resistant Staphylococcus aureus (MRSA) biofilm regulatory and adhesin genes, along with their associated metabolites, constitute the complex molecular machinery required for the formation and maintenance of bacterial biofilms (Foster et al., 2014, PubMed: 24553725). Key regulatory systems like the accessory gene regulator (agr) and staphylococcal accessory regulator (sarA) coordinate the expression of adhesins such as fibronectin-binding proteins (FnbA/B) and clumping factors (ClfA/B), which facilitate initial attachment to host tissues or medical devices (Boles & Horswill, 2008, PubMed: 18402663). The production of metabolites like Polysaccharide Intercellular Adhesin (PIA), encoded by the icaADBC operon, provides a protective matrix that shields the bacteria from the host immune system and antibiotic penetration (Cramton et al., 1999, PubMed: 10347154). These components are critical for the pathogenesis of chronic and device-related infections, making them significant targets for novel anti-biofilm and anti-virulence therapies (Otto, 2013, PubMed: 23549183). Targeting these pathways aims to disrupt the biofilm lifecycle, including attachment, maturation, and dispersal, thereby sensitizing the bacteria to conventional antibiotics (Moormeier & Bayles, 2017, PubMed: 28533616).

Other names

MRSA biofilm factorsStaphylococcal biofilm-associated genesMRSA virulence determinantsMRSA biofilm-associated proteins (BAP)Staphylococcal adhesins

Inhibition of quorum sensing (e.g., Agr system), enzymatic degradation of the extracellular polymeric matrix (e.g., PIA degradation), and interference with surface attachment proteins (adhesins) to prevent colonization and promote biofilm dispersal.